In-stent thrombosis when switching ticagrelor to clopidogrel after percutaneous coronary intervention.


Dual antiplatelet therapy with aspirin and a P2Y12 receptor blocker has been proven to reduce subsequent cardiovascular events and in-stent thrombosis in patients undergoing percutaneous coronary intervention. Newer P2Y12 antagonists with faster onset and greater inhibition of platelet activity have improved cardiovascular outcomes but have created… (More)
DOI: 10.1080/09537104.2016.1235687


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics